Kraken Robotics: Undersea Batteries Drive Solid Revenue Growth

Kraken Robotics (KRKNF) received a 'Buy' rating as its subsea battery capabilities show strengths alongside a surging order backlog. FY2026 revenue guidance was raised to $290–$320M, supported by strong defense/commercial demand and an estimated $120B addressable UUV market by 2035. Gross margin improved to 62% in FY2025, with management projecting a modest dip to 60% in FY2026 as scale-up accelerates to meet higher order intake.

Analysis

The market should focus less on the revenue raise itself and more on what it signals about backlog quality: Kraken is moving from a story-stock to a cash-flow conversion story, which typically supports multiple expansion only if order intake keeps outpacing working-capacity build. The subtle positive is that a defense/commercial mix with rising production scale can create a two-stage re-rate: first on visibility, then on operating leverage as fixed manufacturing and integration costs get absorbed. That said, the slight margin step-down implied for next year is a reminder that this is still an execution trade, not a pure demand trade.

Second-order winners are likely the broader subsea autonomy and sensing ecosystem, including defense primes that need UUV payloads, marine survey contractors, and offshore inspection customers that benefit from lower-cost robotics versus manned missions. The competitive pressure is most acute for legacy sonar, battery, and subsea systems vendors that cannot match Kraken's combination of energy density and integrated stack; if Kraken keeps winning programs, smaller niche incumbents may face pricing pressure or lost-design-win risk over the next 6-18 months. The main loser, if this scales, is anyone selling a fragmented point solution instead of an integrated platform.

The key risk is that TAM narratives for 2035 are too far out to anchor valuation today; near-term price action will be driven by whether the backlog converts without working-capital strain, margin dilution, or schedule slippage. For the next 1-3 months, the catalyst path is simple: confirmatory orders and any evidence that gross margin stays near 60% despite higher volume. Falsifiers are a guide cut, margin slipping below the high-50s, or evidence that backlog is being pulled forward at the expense of quality; if any of those show up, the stock should de-rate quickly.

Key Decisions for Investors

• KRKNF: Buy only on a pullback of 5-10% over the next 1-2 weeks; use it as a small-cap execution bet, not a momentum chase. Upside is a continued re-rate if backlog converts and FY2026 guidance holds; downside is disproportionate if margins miss or liquidity dries up.
• KRKNF vs TDY: Consider a 1-3 month long KRKNF / short TDY pair if borrow is available, targeting relative outperformance from backlog-driven operating leverage. Stop the pair if Kraken gross margin prints below 59% or if order intake slows sequentially.
• If direct ownership is impractical due to OTC liquidity, keep KRKNF on a watchlist and wait for the next quarterly print to verify revenue conversion and cash absorption before entering. This is the cleaner risk/reward than paying up on a headline-driven move.
• Set an alert around the next update on backlog conversion and working capital; if inventory and receivables rise faster than sales, treat it as a warning that the growth is being financed rather than monetized.